Hydrochloric Acid

Hydrochloric Acid

SCHEMBL819992

[Cl-].[Cl-].[Cr+2]C1=C(c2ccccc2)C(c2cccc3cccnc23)c2c1ccc1ccccc21

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 1/20 0.31
KDM4E B2RXH2 4/20 0.38
MAPT P10636 4/20 0.38
SMN1; SMN2 Q16637 4/20 0.38
LMNA P02545 3/20 0.38
TDP1 Q9NUW8 3/20 0.38
CYP3A4 P08684 2/20 0.38
CCR1 P32246 2/20 0.38
CCR5 P51681 2/20 0.38
CCR8 P51685 2/20 0.38
GMNN O75496 1/20 0.38
TP53 P04637 1/20 0.38
HSP90AA1 P07900 1/20 0.38
MMP2 P08253 1/20 0.38
CYP2D6 P10635 1/20 0.38
MMP9 P14780 1/20 0.38
ALOX15 P16050 1/20 0.38
TSHR P16473 1/20 0.38
NFKB1 P19838 1/20 0.38
MMP8 P22894 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1069659 0.83 CCR1 (0.40) KDM4EMAPTSMN1; SMN2LMNATDP1
Hydrochloric Acid SCHEMBL819577 0.82 KDM4E (0.41) KDM4EMAPTSMN1; SMN2LMNATDP1
Hydrochloric Acid SCHEMBL5006798 0.81 PAX8 (0.36) KDM4EMAPTSMN1; SMN2LMNATDP1
Hydrochloric Acid SCHEMBL3078672 0.74 CCR1 (0.36) KDM4EMAPTSMN1; SMN2LMNATDP1
Hydrochloric Acid SCHEMBL1074386 0.73 LMNA (0.39) KDM4EMAPTSMN1; SMN2LMNATDP1
SCHEMBL28517555 0.68 KDM4E (0.54) KDM4EMAPTSMN1; SMN2LMNATDP1
1-Naphthoquinoline SCHEMBL28808797 0.68 LMNA (0.60) KDM4EMAPTSMN1; SMN2LMNATDP1
Phenanthrene SCHEMBL16685315 0.67 CCR1 (0.76) KDM4EMAPTSMN1; SMN2LMNATDP1
Phenanthroline SCHEMBL9275301 0.67 LMNA (0.76) KDM4EMAPTSMN1; SMN2LMNATDP1
1-Naphthoquinoline SCHEMBL29204424 0.67 LMNA (0.58) KDM4EMAPTSMN1; SMN2LMNATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1943281-B1 HYBRID CATALYST SYSTEMS SUPPORTED ON MAGNESIUM HALIDE BASELL POLYOLEFINE GMBH (DE) 2017-09-20 EP disclosed
EP-1740626-B1 CATALYST SYSTEM FOR OLEFIN POLYMERIZATION, ITS PRODUCTION AND USE BASELL POLYOLEFINE GMBH (DE) 2014-10-22 EP disclosed
US-8563674-B2 Polyethylene and catalyst composition for its preparation BASELL POLYOLEFINE GMBH (DE) 2013-10-22 US disclosed
US-20120010377-A1 Catalyst System for the Polymerization of Alpha-Olefins BASELL POLYOLEFINE GMBH (DE) 2012-01-12 US disclosed
US-7928051-B2 Polyethylene for injection moldings BASELL POLYOLEFINE GMBH (DE) 2011-04-19 US disclosed
US-20100311925-A1 Polyethylene and catalyst composition for its preparation BASELL POLYOLEFINE GMBH (DE) 2010-12-09 US disclosed
US-7767613-B2 Polyethylene and catalyst composition for its preparation BASELL POLYOLEFINE GMBH (DE) 2010-08-03 US disclosed
US-7723448-B2 Hybrid catalyst systems supported on magnesium halide BASELL POLYOLEFINE GMBH (DE) 2010-05-25 US disclosed
EP-1753791-B1 POLYETHYLENE FOR INJECTION MOLDINGS BASELL POLYOLEFINE GMBH (DE) 2010-04-14 EP disclosed
US-7671148-B2 Mixing organic transition metal compounds, hydrolyzed organoaluminum compound, and solvent, then impregnating dry porous support BASELL POLYOLEFINE GMBH (DE) 2010-03-02 US disclosed
US-7544826-B2 Monocyclopentadienyl complexes BASELL POLYOLEFINE GMBH (DE) 2009-06-09 US disclosed
US-20090118445-A1 Hybrid Catalyst Systems Supported On Magnesium Halide BASELL POLYOLOLINE GMBH (DE) 2009-05-07 US disclosed
EP-1694689-B1 MONOCYCLOPENTADIENYL COMPLEXES BASELL POLYOLEFINE GMBH (DE) 2009-03-11 EP disclosed
EP-1753794-B9 POLYETHYLENE AND CATALYST COMPOSITION FOR ITS PREPARATION BASELL POLYOLEFINE GMBH (DE) 2009-03-04 EP disclosed
US-20070255033-A1 Polyethylene for Injection Moldings BASELL POYOLEFINE GMBH (DE) 2007-11-01 US disclosed
US-20070213484-A1 Monocyclopentadienyl Complexes BASELL POLYOLEFINE GMBH (DE) 2007-09-13 US disclosed
US-20070213205-A1 Polyethylene and Catalyst Composition for its Preparation BASELL POLYOLEFINE GMBH (DE) 2007-09-13 US disclosed
US-20070207916-A1 Mixing organic transition metal compounds, hydrolyzed organoaluminum compound, and solvent, then impregnating dry porous support BASELL POLYOLEFINE GMBH (DE) 2007-09-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070213484-A1 Monocyclopentadienyl Complexes PCBP1, COASY, PORCN ACHE 4282/4885KDM4E 2568/4885MAPT 1371/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.